TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T43739	Voltage-gated sodium channel alpha Nav1.8	D03FLC	Lamotrigine	Approved	3878	C9H7Cl2N5	256.089	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	IC50 = 96000 nM	Poor binder
T43739	Voltage-gated sodium channel alpha Nav1.8	D0X0RI	Mexiletine	Approved	4178	C11H17NO	179.26	CC1=C(C(=CC=C1)C)OCC(C)N	IC50 = 56000 nM	Poor binder
T43739	Voltage-gated sodium channel alpha Nav1.8	BHJ43T	N-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamide	Investigative	52920492	C22H19N7O2	413.4	C1=CC=C(C=C1)C(=O)NCC2=NOC(=N2)C3=NN(C4=CC=CC=C43)CCN5C=CN=C5	IC50 ~ 100000 nM	Poor binder